FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 169 filers reported holding FATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 9.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $721,975 | +444.1% | 340,554 | +1121.7% | 0.00% | – |
| Q2 2023 | $132,690 | -16.5% | 27,876 | 0.0% | 0.00% | – |
| Q1 2023 | $158,893 | -43.5% | 27,876 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $281,269 | -60.4% | 27,876 | -12.1% | 0.00% | -50.0% |
| Q3 2022 | $711,000 | -9.5% | 31,706 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $786,000 | -35.8% | 31,706 | +0.4% | 0.00% | 0.0% |
| Q1 2022 | $1,224,000 | -33.7% | 31,566 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $1,847,000 | -2.6% | 31,566 | -1.4% | 0.00% | -25.0% |
| Q3 2021 | $1,897,000 | -31.3% | 32,013 | +0.6% | 0.00% | -20.0% |
| Q2 2021 | $2,761,000 | +19.0% | 31,813 | +13.0% | 0.01% | 0.0% |
| Q1 2021 | $2,321,000 | -7.3% | 28,151 | +2.2% | 0.01% | 0.0% |
| Q4 2020 | $2,505,000 | +144.2% | 27,551 | +7.3% | 0.01% | +150.0% |
| Q3 2020 | $1,026,000 | +20.8% | 25,671 | +3.7% | 0.00% | 0.0% |
| Q2 2020 | $849,000 | +54.4% | 24,751 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $550,000 | +13.6% | 24,751 | 0.0% | 0.00% | +100.0% |
| Q4 2019 | $484,000 | +26.0% | 24,751 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $384,000 | -23.5% | 24,751 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $502,000 | +32.1% | 24,751 | +14.6% | 0.00% | 0.0% |
| Q1 2019 | $380,000 | +37.2% | 21,601 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $277,000 | -6.1% | 21,601 | +19.1% | 0.00% | 0.0% |
| Q3 2018 | $295,000 | +43.2% | 18,139 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $206,000 | – | 18,139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |